Company Profile
TherapeuticsMD Stock Price, News & Analysis
- Ticker:
- TXMD
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.09 USD (+0.97%)
Close
Last updated: August 6, 2026
23.6M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, TXMD closed up 0.97% at $2.09. No new same-company headline was identified in the current news window.
Company overview
Pharmaceutical Royalty Company
TherapeuticsMD owns rights to royalties and license revenue from women’s health pharmaceutical products rather than operating a broad internal commercial organization.
Royalty Portfolio Model
Revenue is primarily tied to products licensed under the Mayne agreement, giving TherapeuticsMD exposure to partner sales without directly funding commercialization. The business focuses on collecting contractual economics and preserving remaining intellectual property rights.
Future catalysts
TherapeuticsMD is now largely a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. The market no longer treats it like an active growth name.
Recent news
- 01
TherapeuticsMD Announces First Quarter 2026 Financial Results
Source: TherapeuticsMD
- 02
TherapeuticsMD Announces Full Year 2025 Financial Results
Source: TherapeuticsMD
- 03
TherapeuticsMD Announces Third Quarter 2025 Financial Results
Source: TherapeuticsMD
- 04
TherapeuticsMD Announces Second Quarter 2025 Financial Results
Source: TherapeuticsMD
- 05
TherapeuticsMD Announces First Quarter 2025 Financial Results
Source: TherapeuticsMD
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of TherapeuticsMD (TXMD)?
TherapeuticsMD (TXMD) most recently closed at 2.09 USD, a +0.97% move versus the previous session.
What is the market cap of TherapeuticsMD (TXMD)?
TherapeuticsMD currently has a market capitalization of 23.6M USD on BioPharmSignal.
What does TherapeuticsMD do?
Pharmaceutical Royalty Company TherapeuticsMD owns rights to royalties and license revenue from women’s health pharmaceutical products rather than operating a broad internal commercial organization. Royalty Portfolio Model Revenue is primarily tied to products licensed under the Mayne agreement, giving TherapeuticsMD exposure to partner sales without...
On which exchange is TXMD stock listed?
TherapeuticsMD (TXMD) is associated with NASDAQ, United States, Biopharma.
What is Pharmaceutical?
Pharmaceutical Royalty Company TherapeuticsMD owns rights to royalties and license revenue from women’s health pharmaceutical products rather than operating a broad internal commercial organization.
Which conditions is TherapeuticsMD targeting with Pharmaceutical?
Pharmaceutical Royalty Company TherapeuticsMD owns rights to royalties and license revenue from women’s health pharmaceutical products rather than operating a broad internal commercial organization. Royalty Portfolio Model Revenue is primarily tied to products licensed under the Mayne agreement, giving TherapeuticsMD exposure to partner sales without...
How does TherapeuticsMD describe recent progress with Pharmaceutical?
TherapeuticsMD is now largely a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. The market no longer treats it like an active growth name.
What is Royalty?
Pharmaceutical Royalty Company TherapeuticsMD owns rights to royalties and license revenue from women’s health pharmaceutical products rather than operating a broad internal commercial organization.